View of ASSESSING CLINICAL OUTCOMES OF SGLT2 INHIBITOR THERAPY IN ELDERLY HFrEF PATIENTS WITH AND WITHOUT DIABETES

Return to Article Details ASSESSING CLINICAL OUTCOMES OF SGLT2 INHIBITOR THERAPY IN ELDERLY HFrEF PATIENTS WITH AND WITHOUT DIABETES Download Download PDF